These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37641033)
1. Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China. Zhang X; Yang L; Liu S; Li H; Li Q; Li H; Wang N; Ji J BMC Public Health; 2023 Aug; 23(1):1640. PubMed ID: 37641033 [TBL] [Abstract][Full Text] [Related]
2. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related]
3. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018]. Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820 [No Abstract] [Full Text] [Related]
4. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China. Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604 [TBL] [Abstract][Full Text] [Related]
5. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test. Ribbing Wilén H; Saraste D; Blom J J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615 [TBL] [Abstract][Full Text] [Related]
6. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality. D'Andrea E; Ahnen DJ; Sussman DA; Najafzadeh M Cancer Med; 2020 Jan; 9(2):824-836. PubMed ID: 31777197 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population-based program and meta-analysis. Wang Z; Teng J; Wu W; Dou J; Wong MCS; Gong Y; Huang J; Gu K; Xu W Cancer Med; 2023 Sep; 12(17):18189-18200. PubMed ID: 37578430 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial). Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor]. Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124 [No Abstract] [Full Text] [Related]
10. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design. Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495 [TBL] [Abstract][Full Text] [Related]
11. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019 [TBL] [Abstract][Full Text] [Related]
12. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China. Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442 [TBL] [Abstract][Full Text] [Related]
13. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer. Zorzi M; Battagello J; Selby K; Capodaglio G; Baracco S; Rizzato S; Chinellato E; Guzzinati S; Rugge M Gut; 2022 Mar; 71(3):561-567. PubMed ID: 33789965 [TBL] [Abstract][Full Text] [Related]
14. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants. Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780 [TBL] [Abstract][Full Text] [Related]
15. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China]. Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000 [No Abstract] [Full Text] [Related]
16. Improved risk scoring systems for colorectal cancer screening in Shanghai, China. Wu WM; Gu K; Yang YH; Bao PP; Gong YM; Shi Y; Xu WH; Fu C Cancer Med; 2022 May; 11(9):1972-1983. PubMed ID: 35274820 [TBL] [Abstract][Full Text] [Related]
17. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms. Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812 [TBL] [Abstract][Full Text] [Related]
19. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185 [TBL] [Abstract][Full Text] [Related]
20. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study). González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E; PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]